Skip to content

Tenofovir/ddI: is CD4 cell loss on treatment linked to this combination?

Early virologic failure with ddI/tenofovir plus nevirapine or efavirenz

Kaletra effective and well tolerated in PI-experienced patients

Failure of three main classes of antiretrovirals present in 12% of EuroSIDA cohort

Roche will not go ahead with nelfinavir 625mg formulation in Europe: cites production problems

Keeping track of patients and drugs in rural Haiti: electronic system is practical

HIV protease inhibitors may also check malaria

Core group of patients with drug resistant HIV engaging in risky sex identified by US study

Ranbaxy announces withdrawal of all generic ARVs from WHO list